CureMatch Articles & News
Laguna Niguel, CA – December 13, 2017: Igor F. Tsigelny, Ph.D. and Eden Romm of CureMatch will be presenting at AIMed, the most comprehensive conference on Artificial Intelligence (AI) in medicine, on Wednesday, December 13. Romm and Tsigelny along with Valentina L. Kouznetsova authored “Machine-Learning Models for Selection of Drug-Candidates for Treatment of Alzheimer’s Disease”, one […]
4D Approach to Examining Structural and Functional Changes of Proteins Published in International Computational Intelligence Book SAN DIEGO, CA – December 7, 2017: CureMatch Co-Founders Igor F. Tsigelny, Ph.D. and Razelle Kurzrock, M.D. along with colleagues from UC San Diego and University of Bergen have authored a personalized cancer medicine study examining activation of protein complexes […]
LISBON, PORTUGAL – CureMatch is proud to announce that CureMatch Chief Technology Officer and co-founder, Igor Tsigelny, PhD was invited in November as a plenary speaker to the PCS 4th Annual Global Cancer Conference-2017 in Lisbon, Portugal. The international meeting focused on basic research and clinical cancer research. Presentations and discussions concerning top cancer killers […]
A recent article in HealthcareIT News (Precision medicine clinical decision support system bests oncologists at picking cancer treatment) describes how CureMatch’s clinical decision support platform was used to aid oncologists in the selection of immunotherapy for a 57-year old patient. It explains how a therapy was selected by CureMatch following four previous failed treatment lines, […]
CureMatch has been featured in GenomeWeb’s recent in-depth article, “CureMatch Building Genomic Therapy-Matching Business Focused on Drug Combinations.” The article discusses CureMatch’s innovative product, which guides oncologists in the selection of cancer drugs customized for individual patients based on genomics. The product considers more than 4.5 million different cancer treatment options, including combinations of drugs. […]